Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review

Noémie Rabilloud1, Pierre Allaume2, Oscar Acosta1

  • 1Impact TEAM, Laboratoire Traitement du Signal et de l'Image (LTSI) INSERM, Rennes University, 35033 Rennes, France.

PubMed
Summary

Deep learning (DL), or artificial intelligence (AI), shows strong performance in digital pathology for prostate cancer (PCa) detection and grading. While effective, studies often lack external validation, highlighting areas for improvement in AI applications.